Medartis Holding AG

MDRSF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue$224,831$212,006$182,824$159,880
% Growth6%16%14.4%
Cost of Goods Sold$46,148$44,434$47,435$38,307
Gross Profit$178,683$167,572$135,389$121,573
% Margin79.5%79%74.1%76%
R&D Expenses$43,104$25,906$23,518$17,780
G&A Expenses$38,573$34,480$31,692$25,961
SG&A Expenses$140,505$131,989$126,027$103,047
Sales & Mktg Exp.$101,932$97,509$94,335$77,086
Other Operating Expenses-$12,791$573$0$0
Operating Expenses$170,818$158,468$137,259$110,559
Operating Income$7,865$9,104-$1,870$11,014
% Margin3.5%4.3%-1%6.9%
Other Income/Exp. Net-$5,366-$7,310-$5,274-$2,724
Pre-Tax Income$2,499$1,794-$7,145$8,290
Tax Expense-$1,029$1,174-$1,362$1,452
Net Income$3,528$619-$5,783$6,838
% Margin1.6%0.3%-3.2%4.3%
EPS0.260.051-0.490.58
% Growth413.8%110.3%-184.5%
EPS Diluted0.260.051-0.490.58
Weighted Avg Shares Out13,50012,23211,83411,801
Weighted Avg Shares Out Dil13,50012,27111,83411,801
Supplemental Information
Interest Income$1,326$328$250$135
Interest Expense$5,385$1,727$4,623$1,469
Depreciation & Amortization$22,300$13,254$18,112$16,387
EBITDA$30,184$24,693$16,242$25,430
% Margin13.4%11.6%8.9%15.9%